tiprankstipranks
NervGen Pharma (NGEN)
NASDAQ:NGEN
US Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports

NervGen Pharma (NGEN) Cash flow

84 Followers

NervGen Pharma Cash Flow

NGEN's free cash flow for Q4 2025 was C$-10.13M. For the 2025 fiscal year, NGEN's free cash flow was decreased by C$-7.80M and operating cash flow was C$-10.13M. See a summary of the company’s cash flow.
Cash Flow
Mar 26Mar 25Mar 24Dec 22Dec 21
Operating Cash Flow
C$ -19.50MC$ -11.70MC$ -8.52MC$ -13.12MC$ -6.54M
Investing Cash Flow
C$ 100.93KC$ 40.91KC$ -104.77KC$ -15.57KC$ -35.64K
Financing Cash Flow
C$ 23.76MC$ 15.77MC$ 578.16KC$ 16.70MC$ 15.51M
End Cash Position
C$ 22.07MC$ 12.00MC$ 8.80MC$ 16.56MC$ 13.38M
Free Cash Flow
C$ -19.50MC$ -11.70MC$ -8.53MC$ -13.13MC$ -6.54M
Currency in CAD

NervGen Pharma Cash Flow